Corbus Pharma (CRBP): Narxning daromadga nisbati

Corbus Pharmaceuticals, Inc. (CRBP) tovar belgisi

Qat'iy ta'minot qoidalari va strategik material zaxiralarining saqlanishi Corbus Pharmaceuticals (CRBP) uchun risklarni minimallashtiradi. P/S vaqtlar ketma-ketligi ushbu barqarorlikning bozor qiymatini vizuallashtiradi, bunda 69.50 metrikaning bazaviy ko'rsatkichini aks ettiradi. Biznesning inqirozlarga chidamliligi klinik sinovlarning o'ziga xos tabiati bilan bog'liq, kelajakdagi kapital esa o'smalarni davolash uchun mo'ljallangan antitanachik-dorilar konjugatlarining tijoratlashtirilishiga asoslangan.

CRBP Corbus Pharmaceuticals P/S multiplikatori (04.07.2022 - 13.11.2022)

Corbus Pharmaceuticals (CRBP) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Birja narxi Corbus Pharmaceuticals Holdings, Inc.|CRBP - Maqsadli narxlar grafigi
- birja kapitallashuvi ma'lumotlari:
Bozor qiymati Corbus Pharmaceuticals|CRBP - Kompaniyaning to‘liq qiymati
- emitentning balans qiymati statistikasi:
Bitta aksiya hisobiga sof aktivlar qiymati Corbus Pharmaceuticals|CRBP - Balans kapitallashuvi|Bozor qiymatining xususiy kapitalga nisbati corbuspharma.com|CRBP - Kompaniyaning yakuniy aktivlari
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Corbus Pharmaceuticals|CRBP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Corbus Pharmaceuticals Holdings|CRBP - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Corbus Pharmaceuticals, Inc.|CRBP - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Corbus Pharmaceuticals|Shoshilinch likvidlik corbuspharma.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
CRBP - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Corbus Pharmaceuticals|CRBP - P/E multiplikatori|Forvard P/E multiplikatori Corbus Pharmaceuticals, Inc.|CRBP - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Corbus Pharmaceuticals Holdings|CRBP - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Corbus Pharmaceuticals|CRBP - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi corbuspharma.com|CRBP - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Corbus Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
CRBP - Kompaniya daromadi|Kompaniyaning kelajakdagi daromadi Corbus Pharmaceuticals Holdings|CRBP - P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Corbus Pharmaceuticals Holdings|CRBP - So'nggi 12 oy davomida yillik daromad o'sishi
Kompaniyaning jamlanma tahliliyoti:Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals, Inc. seriyali mahsuloti

Biotehnologiya sektorining yuqori tebranishli klinik sinovlar muhiti uchun Corbus Pharmaceuticals (CRBP) kompaniyasining taxminiy narx-sotuvlar koeffitsiyenti bozor kapitalizatsiyasini haqiqiy sotuvlar hajmi bilan solishtirgan holda, haddan tashqari yuqori baholash filtri vazifasini o'taydi. O'tmishdagi muvaffaqiyatsizliklardan kelib chiqqan investorlar skeptitsizmini hisobga olgan holda, ushbu grafik haddan tashqari qizigan aktivni sotib olishning matematik riskini aniqlash va yangi dori vositalari tijoratlashtirilishidan oldin kapitalning xavfsizlik zaxirasini baholash imkonini beradi.

Raqobatdosh kompaniyalar

INCY - Sotuvga nisbatan narx|Narxning daromadga nisbati hutch-med.com HCM|Nuvation Corp - Narxning daromadga nisbati|DAWN - Narxning daromadga nisbati|Sotuvga nisbatan narx Monopar Therapeutics|INBX: P/S multiplikatori|Narx/daromad multiplikatori I-Mab IMAB|Kapitalizatsiyaning daromadga nisbati FENC|Sotuvga nisbatan narx Heron Therapeutics, Inc. HRTX|Kapitalizatsiyaning daromadga nisbati NVCT (Nuvectis Pharma, Inc.)|CHRS (Coherus BioSciences) - Bozor kapitallashuvining daromadga nisbati|Cardiff Oncology - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati BYSI (BeyondSpring)|BioAtla - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati LIXT (Lixte Biotechnology Holdings)|CTXR: P/S multiplikatori|Sotuvga nisbatan narx cellectar.com (CLRB)|Narxning daromadga nisbati BioLineRx|CANF: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori APRE|P/S multiplikatori Kazia Therapeutics Ltd (KZIA)|Narxning daromadga nisbati Silexion Therapeutics Corp. SLXN|NCNA (nucana.com) - Narxning sotuvga nisbati|CMRX: Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx Cyclacel|GTHX: P/S multiplikatori|Kronos Bio Corporation (KRON) - P/S multiplikatori|KTRA (kintara.com) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ONCT (Oncternal Therapeutics)|Narxning daromadga nisbati Portage Biotech (PRTG)